Brimonidine tartrate 0.33 % gel for the prevention and management of hand-foot syndrome

J Dtsch Dermatol Ges. 2019 May;17(5):552-554. doi: 10.1111/ddg.13829. Epub 2019 Mar 28.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / drug therapy
  • Antibiotics, Antineoplastic / therapeutic use
  • Brimonidine Tartrate / administration & dosage*
  • Dermatologic Agents / therapeutic use*
  • Doxorubicin / therapeutic use
  • Endometrial Neoplasms / complications
  • Endometrial Neoplasms / drug therapy
  • Female
  • Hand-Foot Syndrome / complications
  • Hand-Foot Syndrome / drug therapy*
  • Humans
  • Middle Aged

Substances

  • Antibiotics, Antineoplastic
  • Dermatologic Agents
  • Brimonidine Tartrate
  • Doxorubicin